NCT00140374View on ClinicalTrials.gov

Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 1998

Study Completion Date

February 28, 2001

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

Immunotherapy allogeneic GM-CSF secreting cellular vaccine

Sponsors

Lead Sponsor

Cell Genesys
All Listed Sponsors
lead

Cell Genesys

INDUSTRY